Clearwater International advises Priogen on its sale to Gilde Equity Management
Clearwater International has advised Priogen, a portfolio company of Triacta, on its sale to Gilde Equity Management, an independent private equity firm based in Houten, the Netherlands.
Priogen focuses on short-term trading and imbalance risk management in European power markets, specialising in capitalising on market imperfections, through its exceptional forecasting skills. With strong expertise in leveraging power demand and supply forecasting capabilities, Priogen has grown into a well-established trading company, operating multiple short-term trading strategies via market access providers, on centralised European trade platforms.
Gilde Equity Management invests in businesses based in the Benelux region which have international aspirations. Gilde’s operations include business successions, privatisation, and management buyouts.